Antioxidants: potential antiviral agents for Japanese encephalitis virus infection
- PMID: 24780919
- DOI: 10.1016/j.ijid.2014.02.011
Antioxidants: potential antiviral agents for Japanese encephalitis virus infection
Abstract
Japanese encephalitis (JE) is prevalent throughout eastern and southern Asia and the Pacific Rim. It is caused by the JE virus (JEV), which belongs to the family Flaviviridae. Despite the importance of JE, little is known about its pathogenesis. The role of oxidative stress in the pathogenesis of viral infections has led to increased interest in its role in JEV infections. This review focuses mainly on the role of oxidative stress in the pathogenesis of JEV infection and the antiviral effect of antioxidant agents in inhibiting JEV production. First, this review summarizes the pathogenesis of JE. The pathological changes include neuronal death, astrocyte activation, and microglial proliferation. Second, the relationship between oxidative stress and JEV infection is explored. JEV infection induces the generation of oxidants and exhausts the supply of antioxidants, which activates specific signaling pathways. Finally, the therapeutic efficacy of a variety of antioxidants as antiviral agents, including minocycline, arctigenin, fenofibrate, and curcumin, was studied. In conclusion, antioxidants are likely to be developed into antiviral agents for the treatment of JE.
Keywords: Antioxidant; Antivirus agents; Japanese encephalitis virus; Oxidative stress.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.J Neurochem. 2008 Jun;105(5):1582-95. doi: 10.1111/j.1471-4159.2008.05238.x. Epub 2008 Jan 18. J Neurochem. 2008. PMID: 18208541
-
Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan.J Antimicrob Chemother. 2008 Mar;61(3):679-88. doi: 10.1093/jac/dkm503. Epub 2008 Jan 29. J Antimicrob Chemother. 2008. PMID: 18230688
-
TNF-α and IL-1β mediate Japanese encephalitis virus-induced RANTES gene expression in astrocytes.Neurochem Int. 2011 Feb;58(2):234-42. doi: 10.1016/j.neuint.2010.12.009. Epub 2010 Dec 16. Neurochem Int. 2011. PMID: 21167894
-
Natural products and derivatives as Japanese encephalitis virus antivirals.Pathog Dis. 2024 Feb 7;82:ftae022. doi: 10.1093/femspd/ftae022. Pathog Dis. 2024. PMID: 39317665 Free PMC article. Review.
-
Japanese encephalitis and Japanese encephalitis virus in mainland China.Rev Med Virol. 2012 Sep;22(5):301-22. doi: 10.1002/rmv.1710. Epub 2012 Mar 8. Rev Med Virol. 2012. PMID: 22407526 Review.
Cited by
-
Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail.Inflamm Res. 2022 Nov;71(10-11):1159-1167. doi: 10.1007/s00011-022-01615-w. Epub 2022 Aug 8. Inflamm Res. 2022. PMID: 35941297 Free PMC article. Review.
-
Transcriptome analysis of interactions between silkworm and cytoplasmic polyhedrosis virus.Sci Rep. 2016 Apr 27;6:24894. doi: 10.1038/srep24894. Sci Rep. 2016. PMID: 27118345 Free PMC article.
-
Elevation of Cleaved p18 Bax Levels Associated with the Kinetics of Neuronal Cell Death during Japanese Encephalitis Virus Infection.Int J Mol Sci. 2019 Oct 10;20(20):5016. doi: 10.3390/ijms20205016. Int J Mol Sci. 2019. PMID: 31658698 Free PMC article.
-
Amelioration of oxidative stress using N-acetylcysteine in canine parvoviral enteritis.J Vet Pharmacol Ther. 2018 Feb;41(1):68-75. doi: 10.1111/jvp.12434. Epub 2017 Jul 12. J Vet Pharmacol Ther. 2018. PMID: 28703421 Free PMC article. Clinical Trial.
-
Japanese Encephalitis Virus-Infected Cells.Subcell Biochem. 2023;106:251-281. doi: 10.1007/978-3-031-40086-5_10. Subcell Biochem. 2023. PMID: 38159231
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical